A state where the Hypothalamic-Pituitary-Adrenal (HPA) axis exhibits reduced responsiveness, often characterized by lower baseline cortisol output or blunted peak response to acute stressors. This downregulation can be a maladaptive response to chronic, unresolved stress or prolonged high levels of circulating glucocorticoids. Clinically, this state can present as fatigue, diminished stress coping capacity, and altered metabolic regulation. It signifies a shift in the body’s primary adaptive response system.
Origin
The term is derived directly from neuroendocrinology, specifically the hierarchical structure governing the stress response, starting at the Hypothalamus (CRH), signaling the Pituitary (ACTH), and finally stimulating the Adrenals (Cortisol). Downregulation describes the negative feedback mechanism becoming overly sensitive or the end-organ response becoming fatigued.
Mechanism
Prolonged exposure to high cortisol levels induces negative feedback at the pituitary and hypothalamic levels, inhibiting CRH and ACTH release, thus reducing adrenal stimulation. Furthermore, peripheral tissues may become less sensitive to circulating cortisol due to receptor desensitization or sequestration. Therapeutic optimization aims to gently restore sensitivity and reset the set-point of this critical feedback loop.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.